STATISTICS
Statistics for 3-cell-type analyses
Monocytes | CD4+ T cells | Neutrophils | ||
---|---|---|---|---|
Demographic characteristics of study subjects | N | 102 | 102 | 94 |
Males, N (%) |
48 (47.1) | 49 (48.0) | 48 (51.1) | |
Median age (range) |
62.5 (35–75) | 62.0 (35–75) | 58.0 (24–81) | |
DNAm profiles | Sequencing depth1 |
31.1 ± 1.8 | 31.0 ± 1.6 | 54.7 ± 1.6 |
# autosomal CpGs2 |
23,941,821 | 24,037,518 | 25,483,031 | |
Gene expression profiles | # sequencing reads1 |
33,917,157 ± 3,153,528 |
35,175,996 ± 1,275,575 |
46,409,683 ± 6,731,058 |
# genes3 | 16,789 | 18,894 | 14,534 | |
SNV profiles | # SNVs4 | 8,945,669 | 8,951,822 | 8,792,880 |
1Average ± standard deviation
2CpGs that were retained in ≥ 50% of subjects for each cell type
3Genes that were expressed with a FPKM ≥ 0.1 in ≥ 50% of subjects for each cell type
4SNVs with a MAC > 1 (MAC: minor allele count)
Abbreviations: DNAm, DNA methylation; FPKM, fragments per kilobase of exon per million mapped fragments; SNV, single nucleotide variant.
#. CpGs with call rate >= 50% | |||
---|---|---|---|
Chr | Monocytes | CD4+ T cells | Neutrophils |
1 | 2,042,138 | 2,050,589 | 2,169,599 |
2 | 1,924,655 | 1,934,169 | 2,061,342 |
3 | 1,454,563 | 1,461,634 | 1,562,224 |
4 | 1,275,761 | 1,283,597 | 1,390,178 |
5 | 1,326,857 | 1,333,428 | 1,427,409 |
6 | 1,321,901 | 1,328,810 | 1,417,880 |
7 | 1,379,804 | 1,385,406 | 1,476,474 |
8 | 1,158,964 | 1,163,948 | 1,238,085 |
9 | 1,042,018 | 1,046,651 | 1,111,494 |
10 | 1,213,368 | 1,218,112 | 1,285,846 |
11 | 1,180,273 | 1,183,442 | 1,247,761 |
12 | 1,161,284 | 1,166,091 | 1,236,094 |
13 | 706,826 | 710,512 | 765,997 |
14 | 779,218 | 779,549 | 827,813 |
15 | 766,453 | 769,697 | 814,282 |
16 | 987,665 | 990,124 | 1,034,331 |
17 | 1,070,104 | 1,073,533 | 1,117,390 |
18 | 610,896 | 613,615 | 652,750 |
19 | 994,754 | 996,078 | 1,031,712 |
20 | 675,502 | 677,115 | 703,058 |
21 | 340,618 | 342,081 | 361,974 |
22 | 528,199 | 529,337 | 549,338 |
Autosomal | 23,941,821 | 24,037,518 | 25,483,031 |
Statistics for 8-cell-population analyses
Neutrophils | Monocytes | CD4+ T cells | CD8+ T cells | ||
---|---|---|---|---|---|
Demographic characteristics | N | 20 | 20 | 20 | 20 |
Males, N (%) |
10 (50) | 10 (50) | 10 (50) | 10 (50) | |
Median age (SD) |
48.5 (11.9) | 48.5 (11.9) | 48.5 (11.9) | 48.5 (11.9) | |
DNAm profiles | Sequencing depth1 |
7.2 ± 1.0 | 7.1 ± 0.7 | 6.8 ± 0.8 | 7.2 ± 0.8 |
# autosomal CpGs2 |
26,030,767 | 26,017,342 | 26,012,680 | 26,038,299 |
B cells | NK cells | PBMCs | Leukocytes | ||
---|---|---|---|---|---|
Demographic characteristics | N | 20 | 20 | 20 | 20 |
Males, N (%) |
10 (50) | 10 (50) | 10 (50) | 10 (50) | |
Median age (SD) |
48.5 (11.9) | 48.5 (11.9) | 48.5 (11.9) | 48.5 (11.9) | |
DNAm profiles | Sequencing depth1 |
7.4 ± 0.8 | 7.2 ± 0.8 | 7.0 ± 0.8 | 7.0 ± 0.9 |
# autosomal CpGs2 |
24,311,000 | 26,023,559 | 26,032,316 | 26,033,709 |
1Average ± standard deviation.
2CpGs that were retained in ≥ 50% of subjects for each cell type.
Statistics for PBMC analyses (n=656)
PBMC | ||||
---|---|---|---|---|
Demographic characteristics | N | 656 | ||
Males, N (%) |
188 (28.7) | |||
Median age (SD) |
53 (14.3) | |||
DNAm profiles | Read depth of CpGs1 |
30.6 ± 25.4 | ||
# autosomal CpGs |
5,029,453 |
1Average ± standard deviation.
Statistics for 3-cell-type QTL analyses
Monocytes | CD4+ T cells | Neutrophils | ||
---|---|---|---|---|
eQTL analysis | # test | 92,860,381 (32,833,338) |
106,067,569 (32,833,338) |
141,827,132 (32,833,338) |
# eQTL1 (SNV-Gene pair) |
463,082 (185,997) |
472,190 (76,659) |
3,294 (79,779) |
|
eQTM analysis | # test | 380,940,810 (7,546,301) |
410,461,826 (7,546,301) |
520,221,300 (7,546,301) |
# eQTM1 (CpG-Gene pair) |
5,730 (634) |
2,609,764 (4,189) |
238 (2,944) |
|
mQTL analysis | # test | 3,398,929,030 (1,219,472,361) |
3,255,830,847 (1,219,472,361) |
3,799,884,224 (1,219,472,361) |
# mQTL1 (SNV-CpG pair) |
44,032,528 (1,085,948) |
72,594,605 (3,151,144) |
83,464,257 (3,254,887) |
1A significance threshold of q = 0.05 (FDR adjusted p value) was applied.
Statistics for PBMC QTL analyses (n=384)
PBMC | ||
---|---|---|
eQTL analysis | # test | 4,354,557 |
# eQTL (SNV-Gene pair)1 | 546,367 | |
eQTM analysis | # test | 826,987 |
# eQTM (CpG-Gene pair)1 | 179,828 | |
mQTL analysis | # test | 17,471,105 |
# mQTL (SNV-CpG pair)1 | 5,637,700 |
1A significance threshold of q = 0.05 (FDR adjusted p value) was applied.
Statistics for kidney cancer EWAS samples
Phase1 Case |
Phase1 Ctrl |
Phase2 Case |
Phase2 Ctrl |
||
---|---|---|---|---|---|
Demographic characteristics |
n | 50 | 50 | 48 | 48 |
Male, N (%) |
38 (76.0) | 38 (76.0) | 37 (77.1) | 37 (77.1) | |
Mean age (SD) |
61.1 (12.3) | 61.0 (12.4) | 64.1 (10.7) | 64.5 (10.4) | |
DNAm profiles |
Sequencing depth1 |
36.1 ± 2.2 | 36.8 ± 3.1 | 24.9 ± 1.7 | 23.9 ± 1.9 |
# autosomal CpG2 |
2,993,338 | 2,993,338 | 1,318,169 | 1,318,169 |
1Average ± standard deviatio.
2CpGs that were retained in >=50% call rate.